Lanthanum Carbonate (BAY77-1931)

DRUG3 trials

Sponsors

Bayer

Conditions

DialysisHyperphosphatemia

Phase 2

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

CompletedNCT00767637

BayerDialysis, Hyperphosphatemia

Start: 2005-06-30End: 2008-10-31Updated: 2014-06-20

Phase 3

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

CompletedNCT01514851

BayerHyperphosphatemia

Start: 2006-01-31End: 2006-05-31Updated: 2012-06-08

Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients

CompletedNCT01518387

BayerHyperphosphatemia

Start: 2006-01-31End: 2006-07-31Updated: 2016-03-14